Related Experiment Video

Updated: Jul 5, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells

Gargi Bagchi1, Juanjuan Wu, John French

  • 1Department of Pathology, Medical College of Georgia, Augusta, GA 30912, USA.

Cancer Research
|May 3, 2008
PubMed

Insights

Androgens rapidly activate protein kinase A (PKA) through a non-genomic pathway in prostate cells, independent of the nuclear androgen receptor (AR). This PKA activation is crucial for androgen-driven prostate cancer cell proliferation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Androgens are key regulators of male reproductive organ development and prostate cancer.
  • Androgen action occurs via genomic and rapid non-genomic pathways.
  • Genomic androgen responses require cyclic AMP (cAMP)-dependent protein kinase (PKA) activity.

Purpose of the Study:

  • To investigate the rapid, non-genomic signaling pathways activated by androgens in prostate cells.
  • To determine the role of protein kinase A (PKA) in androgen-mediated prostate cell proliferation.
  • To explore novel therapeutic strategies for prostate cancer targeting PKA.

Main Methods:

  • Investigated androgen-induced PKA activation in prostate cells.
  • Utilized nuclear AR antagonist bicalutamide to differentiate pathways.
  • Employed siRNA to reduce G alpha-s expression and assess PKA activation.
  • Measured androgen-induced prostate cell proliferation.

Main Results:

  • Androgen rapidly activates PKA in prostate cells via a cAMP-dependent mechanism.
  • This PKA activation is independent of nuclear AR and bicalutamide.
  • G alpha-s signaling mediates androgen-induced PKA activation.
  • Inhibition of PKA attenuates androgen-induced prostate cell proliferation.

Conclusions:

  • Androgen activates a non-genomic pathway to rapidly engage PKA in prostate cells.
  • This non-genomic PKA activation is essential for the genomic functions of the nuclear AR.
  • Targeting PKA alongside AR-therapies may enhance prostate cancer treatment efficacy.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...